Bruker Corporation (BRKR)
| Bid | 44.24 |
| Market Cap | 6.75B |
| Revenue (ttm) | 3.37B |
| Net Income (ttm) | 113.18M |
| EPS (ttm) | 0.76 |
| PE Ratio (ttm) | 58.53 |
| Forward PE | 20.73 |
| Analyst | Hold |
| Ask | 45.09 |
| Volume | 1,145,485 |
| Avg. Volume (20D) | 1,920,835.8 |
| Open | 44.72 |
| Previous Close | 44.45 |
| Day's Range | 44.20 - 45.48 |
| 52-Week Range | 43.51 - 94.64 |
| Beta | 1.18 |
About BRKR
Bruker Corporation develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions in the United States and internationally. The company operates through three segments: Bruker Scientific Instruments (BSI) Life Science, BSI NANO, and Bruker Energy & Supercon Technologies. It offers life science tools, and single and multiple modality systems; life science mass spectrometry; MALDI Biotyper rapid pathogen ide...
Analyst Forecast
According to 10 analyst ratings, the average rating for BRKR stock is "Hold." The 12-month stock price forecast is $68, which is an increase of 52.86% from the latest price.
Stock ForecastsNext Earnings Release
Analysts project revenue of ... Unlock content with Pro Subscription
1 month ago · businesswire.com
Bruker Spatial Biology to Announce Groundbreaking Advances at AGBT 2025BILLERICA, Mass.--(BUSINESS WIRE)---- $BRKR #BRKR--Bruker Corporation (Nasdaq: BRKR) announced today that it will unveil significant advancements in spatial biology at the 2025 Advances in Genome Biol...
